Home  >   401k Directory   >   Alnylam Pharmaceuticals, Inc.
 
Company:
Alnylam Pharmaceuticals, Inc.
Plan:
Alnylam Pharmaceuticals, Inc. Savings & Investment Plan
 

Alnylam Pharmaceuticals, Inc.

83 Plan: Alnylam Pharmaceuticals, Inc. Savings & Investment Plan

 
 
83
45
78
89
0
10
20
30
40
50
60
70
80
90
100
For the average 401k participant, the 6 point difference between this plan's BrightScope Rating (83) and the top rated plan (89) could equate to:
[How is this calculated?]
5 additional years of work
Up to $62,600 in lost retirement savings.
The delay in retirement calculations apply solely to this defined contribution plan and do not take into account other retirement plans and programs offered by this employer.

 

Retirement Plan Description

Alnylam Pharmaceuticals, Inc. Savings & Investment Plan is a defined contribution plan with a 401k feature. This plan has a BrightScope Rating of 83. This plan is in the top 15% of plans for Account Balances and Salary Deferral. Alnylam Pharmaceuticals, Inc. Savings & Investment Plan currently has over 200 active participants and over $22.8M in plan assets.


 Investment Menu Statistics

No. of Investment Options
22
Plan Average: 20
Largest Funds in this 401k: based on % allocation of assets
1. Alnylam Pharmaceuticals, Inc. Common Stock 33%
2. Fidelity Advisor New Insights 7%
3. Columbia Acorn 5%

 Retirement Plan Details

Address 300 Third Street
3rd Floor
Cambridge, MA 02142 
Industry Professional, Scientific, and Technical Services
Administrator Carole Cassidy
Net Plan Assets $22,800,000
Total Participants 230
Avg Account Balance $110,000

 
Plan Service Providers

Recordkeeper Fidelity
Auditor McGladrey Wealth Management LLC